Eyestem Research Pvt. Ltd., a clinical-stage biotechnology company pioneering scalable cell therapy solutions for retinal diseases, announced the successful presentation of its groundbreaking phase one clinical trial results at the 3rd China Great Bay Cell and Gene Therapy Forum (Innoxbio CGT
